2 results
Approved WMOPending
To determine the efficacy of intravitreal 2.0 mg OPT-302 when administered in combination with intravitreal 2.0 mg aflibercept, in participants with neovascular AMD.
Approved WMORecruiting
Primary Objective: to assess the feasibility of the use of BabyCheck combined with standard PO for infants < six months of age presented at the emergency GP post. Secondary Objective(s): 1. To assess the sensitivity and specificity of theā¦